Skip to Content

Phreesia Inc PHR

Morningstar Rating
$21.20 +0.04 (0.19%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHR is trading at a 133% premium.
Price
$21.27
Fair Value
$65.78
Uncertainty
Very High
1-Star Price
$35.23
5-Star Price
$17.68
Economic Moat
Nnx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHR is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$21.16
Day Range
$20.8422.00
52-Week Range
$12.0534.98
Bid/Ask
$0.00 / $30.58
Market Cap
$1.22 Bil
Volume/Avg
1.1 Mil / 467,332

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.14
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.43%

Company Profile

Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Core
Total Number of Employees
1,438

Comparables

Valuation

Metric
PHR
CMAX
NORDH
Price/Earnings (Normalized)
Price/Book Value
4.810.522.75
Price/Sales
3.140.015.77
Price/Cash Flow
212.54
Price/Earnings
PHR
CMAX
NORDH

Financial Strength

Metric
PHR
CMAX
NORDH
Quick Ratio
1.620.292.39
Current Ratio
1.760.312.39
Interest Coverage
−56.32−9.17−1,270.38
Quick Ratio
PHR
CMAX
NORDH

Profitability

Metric
PHR
CMAX
NORDH
Return on Assets (Normalized)
−17.07%−18.59%−10.46%
Return on Equity (Normalized)
−24.17%−47.72%−11.87%
Return on Invested Capital (Normalized)
−23.35%−12.91%−12.17%
Return on Assets
PHR
CMAX
NORDH
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
Mgxtrfr$35.6 Bil
Veeva Systems Inc Class A
VEEV
ZtxpdyddCwhcz$29.6 Bil
Pro Medicus Ltd
PMCUF
Kyrxxb$9.9 Bil
Solventum Corp
SOLV
Hkqhxw$9.1 Bil
HealthEquity Inc
HQY
Gbbgrks$7.5 Bil
M3 Inc
MTHRF
Yycxm$6.5 Bil
M3 Inc ADR
MTHRY
Prkxxl$6.5 Bil
Tempus AI Inc Class A common stock
TEM
Xqmt$5.8 Bil
R1 RCM Inc
RCM
Bmpb$5.3 Bil
Doximity Inc Class A
DOCS
Qmfrn$5.2 Bil

Sponsor Center